Strides Pharma Science reports standalone net loss of Rs 14.30 crore in the September 2018 quarter

Sales decline 6.39% to Rs 338.43 crore

Net loss of Strides Pharma Science reported to Rs 14.30 crore in the quarter ended September 2018 as against net profit of Rs 12.56 crore during the previous quarter ended September 2017. Sales declined 6.39% to Rs 338.43 crore in the quarter ended September 2018 as against Rs 361.53 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales338.43361.53 -6 OPM %-1.003.51 -PBDT5.6228.14 -80 PBT-15.619.33 PL NP-14.3012.56 PL

Powered by Capital Market - Live News